CLOV vs XERS · rev $1.37B vs rev $203.1M
Clover Health Investments Corp (CLOV) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XERS revenue for 2024-12-31 was $203.1M. Net income was -$54.8M. Revenue was up 399.7% from 2024-03-31 to 2024-12-31. XERS currently screens at market cap $760.7M.
CLOV currently screens at market cap $1.55B. XERS currently screens at market cap $760.7M.
Not investment advice. Open the CLOV and XERS stock pages for the full models.
Not investment advice.